Weaving the AI Threads Together: Essential Conversations for Integrating AI in Healthcare Transformation
The following is a guest article by Demetri Giannikopoulos, Vice President of Innovation at Aidoc
In the ever-evolving landscape of AI, 2024 stands out as the year where artificial intelligence is poised to claim the coveted title of Merriam-Webster’s word of the year. Nowhere is the buzz around AI more palpable than in healthcare circles, where the promise of AI to revolutionize a complex and, in many ways, fragmented system looms large.
Despite notable successes, many AI solutions have fallen short, showcasing potential only in specific areas or departments. Why? Often, AI is treated as a technological bandage. Teams ...
Source: EMR and HIPAA - March 18, 2024 Category: Information Technology Authors: Guest Author Tags: AI/Machine Learning C-Suite Leadership Health IT Company Healthcare IT Hospital - Health System Interoperability AI Integration aidoc Artificial Intelligence Clinical AI Demetri Giannikopoulos Healthcare AI Healthcare Transformatio Source Type: blogs
Veradigm to Acquire ScienceIO
Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare
Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Customers
Acquisition Will Help Accelerate Platform Improvements Across the Veradigm Network, including the Provider, Payer, and Life Sciences Businesses
Next-Generation Products Expected to Improve Outcomes and Lower Costs Across the Healthcare Ecosystem
Positions Veradigm for the Future as Higher Margin Technology and Data Products Company
...
Source: EMR and HIPAA - March 18, 2024 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Dr. Yin Ho Greg Garrison Health IT Acquisitions Healthcare M&A ScienceIO Tom Langan Veradigm Veradigm Inc. Will Manidis Source Type: blogs
Trial By Error: Professor Chris Ponting on the NIH ’ s Findings and the Latest on the Genome-Wide Association Study Update
By David Tuller, DrPH When the US National Institutes of Health released its lengthy ME/CFS study last month with much fanfare and publicity, the London-based Science Media Centre asked Professor Chris Ponting, among other experts, to provide comment. The study–“Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome”–was published by Nature Communications. It included in-depth findings … Trial By Error: Professor Chris Ponting on the NIH’s Findings and the Latest on the Genome-Wide Association Study Update Read More » (Source: virology blog)
Source: virology blog - March 18, 2024 Category: Virology Authors: David Tuller Tags: Uncategorized Source Type: blogs
Will Americans Get PBM Reform in 2024? Maybe, But Many Things Need to Happen I Order to Get There. On the Upside: Insulin Has Opted Out of PBM Sales.
At the core of this post is a YouTube video which can be viewed in the middle of this blog post. The subject is about whether we ' ll get much-needed legislation passed into law to reform corrupt Pharmacy Benefit Managers (PBMs) which we know with absolute certainty were at fault for runaway insulin prices. At least that was true until March 2023, when the three largest insulin manufacturers, starting withLilly, followed byNovo Nordisk and shortly thereafter,Sanofi all announced major insulin list price reductions in the range of 70% to 78%. Think about that for a second: Imagine being able to instantly...
Source: Scott's Web Log - March 17, 2024 Category: Endocrinology Tags: 2024 Congress insulin prices PBM rebates reform Source Type: blogs
Will Americans Get PBM Reform in 2024? Maybe, But Many Things Need to Happen In Order to Get There. On the Upside: Insulin Has Opted Out of PBM Sales.
At the core of this post is a YouTube video which can be viewed in the middle of this blog post. The subject is about whether we ' ll get much-needed legislation passed into law to reform corrupt Pharmacy Benefit Managers (PBMs) which we know with absolute certainty were at fault for runaway insulin prices. At least that was true until March 2023, when the three largest insulin manufacturers, starting withLilly, followed byNovo Nordisk and shortly thereafter,Sanofi all announced major insulin list price reductions in the range of 70% to 78%. Think about that for a second: Imagine being able to instantly...
Source: Scott's Web Log - March 17, 2024 Category: Endocrinology Tags: 2024 Congress insulin prices PBM rebates reform Source Type: blogs
What is the risk of ACS after PCI in a CTO related artery ?
CTOs are opened primarily for four reasons
Angina which is refractory to drugs
Stress test positivity with or without angina
Anxiety of having a blocked coronary artery in a self educated patient
Cardiologist’s clandestine pride & pursuit*
* Personal experience included
Some evidence based observation
Most of the studies as on today do not give survival advantage of opening a CTO.(DECISION-CTO,EURO-CTO,EXPLORE,IMPACTOR)
Opening a CTO, for reasons other than angina (i.e. for relief of dyspnea or improving functional capacity) is largely conjectural and based on randomly accrued data back...
Source: Dr.S.Venkatesan MD - March 16, 2024 Category: Cardiology Authors: dr s venkatesan Tags: Uncategorized cto cto hardware cto trials jcto score open artery hypothesisacc esc aha guidelines Source Type: blogs
Efforts to Produce Drugs to Slow or Reverse Sarcopenia Benefit from the Semaglutide Hype
This popular science article is a reminder that all too little in this world happens for entirely rational reasons. Drugs aimed at slowing or reversing the age-related loss of muscle mass leading to sarcopenia are presently under development by a number of companies, though none of the candidates discussed are producing effect sizes that look very favorable in comparison to the effects of resistance exercise. These efforts will likely benefit from the present manufactured hype that attends the use of antidiabetic GLP1 receptor agonists for weight loss, as one of the side-effects of this drug is modest loss of muscle mass. ...
Source: Fight Aging! - March 15, 2024 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Denoising with DxO PureRaw4
The kind folks at DxO let me have a copy of the latest version of PureRaw ahead of launch last month and so I’ve been using that to process my RAW photos from my camera for a few weeks now. It does an excellent job of basically knocking out noise to the equivalent of about 3 stops of ISO.
So, if I were shooting birds in flight at dusk and the camera needed an ISO of 6400 to compensate for a short shutter speed, then PureRaw4 is giving me the photo as if I’d shot at ISO 800, which is a lot less noise than one gets at ISO 6400 on a 2/3 frame camera like the Canon R7, especially with my big Sigma lens zoomed in to...
Source: David Bradley Sciencebase - Songs, Snaps, Science - March 14, 2024 Category: Science Authors: David Bradley Tags: Photography Source Type: blogs
What could we do if GLP-1 weight loss drugs were free? Would our obesity epidemic be solved for good?
By CECI CONNOLY and SAMI INKINEN
Unless you have been living under a rock, you likely have heard the names Ozempic, Wegovy or Mounjaro. Or perhaps been humming the jingle. Rarely has a class of drugs (in this case, GLP-1s) achieved such widespread attention in popular culture and the media, which has people clamoring for them in every doctor’s office in the nation.
And for good reason. What we know is that the efficacy and safety profile of these medications is substantially better than any weight loss drug in the past, while our obesity epidemic has only ballooned. As organizations committed to sound science and h...
Source: The Health Care Blog - March 13, 2024 Category: Consumer Health News Authors: matthew holt Tags: Health Policy ACHP Ceci Connoly GLP-1s Obesity Sami Inkinen virta Source Type: blogs
Science Snippet: Examining Enzymes
Structure of a pyruvate kinase, an enzyme that adds a phosphate group to adenosine diphosphate (ADP) to make adenosine triphosphate (ATP). Credit: PDB 7UEH.
Every day, our cells must produce all the various molecules they need to stay alive. But the chemical reactions to create these molecules can’t occur without help—which is where enzymes come in. Enzymes are biological catalysts, meaning they speed up the rate of specific chemical reactions by reducing the amount of energy needed for the reaction to occur. Most enzymes are proteins, but some RNA molecules can also act as enzymes.
Thousands of different enzymes ...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - March 13, 2024 Category: Research Authors: Chrissa Chverchko Tags: Cells Chemistry, Biochemistry and Pharmacology Cellular Processes Proteins Science Snippet Source Type: blogs
How do we stop a resurgence of fascism?
Is it bad to write for hard-right outlets?
There is no doubt that the Overton window has shifted to the right during the last decade or two. It is now common to hear people saying things that, even in 2010 would have been thought to be frankly fascistic.
I recall a conversation with the great biophysicist, Sir Bernard Katz, in 1992. He had come to UCL in 1936 to escape from the Nazi regime in Leipzig. When I suggested to him that he must have been very pleased about the reunification of Germany, he pulled a long face and said “hmm, let’s wait to see what crawls out from under stones”. ...
Source: DC's goodscience - March 11, 2024 Category: Science Authors: David Colquhoun Tags: Uncategorized Alan Sokal anti-vaccination antiscience Deborah Cohen fascism Margaret McCartney Paul Marshall Quillette sceptics skeptics Spiked Toby Young transgender UnHerd Source Type: blogs
“ Exercise ” – what does it do for people living with persistent pain?
No, I’m not going to assemble a bunch of papers and point out the effect sizes of exercise on pain and disability! In fact, I’m not even going to point to much research in this post. I want to pose some questions and put some thoughts out for discussion.
See, the people I’ve seen over the years who live with pain have, by and large, not been great ‘exercisers’ before their pain came on, and many haven’t really changed their lifestyle a heap since their pain either. In fact, there is research showing that people with chronic pain don’t change the overall quantity of their activit...
Source: HealthSkills Weblog - March 10, 2024 Category: Anesthesiology Authors: BronnieLennoxThompson Tags: Assessment Chronic pain Clinical reasoning Occupational therapy Physiotherapy Psychology Resilience Science in practice Health Research Source Type: blogs
Unlock Your Brain ’ s Hidden Potential With This Simple Nature Hack (M)
The wisdom of naturalists like Thoreau validated by science as researchers unveil the mental benefits of nature immersion. (Source: PsyBlog | Psychology Blog)
Source: PsyBlog | Psychology Blog - March 10, 2024 Category: Psychiatry & Psychology Authors: Jeremy Dean Tags: Attention subscribers-only Source Type: blogs
PickBait
So much of what shows up on social media, Threads in particular, it seems, is what might be referred to as “engagement bait”. It’s often inane or perhaps an inflammatory comment, it could be a boring or open-ended question, a reboots of stuff from other places that might be years old, some cliched statement with no qualification, for instance. It all seems like a rather pathetic and lame attempt to boost one’s reach and gain attention, to get interactions for the sake of interaction. I won’t embarass anyone by sharing examples, they’re endless anyway and it would take weeks.
The phrase &...
Source: David Bradley Sciencebase - Songs, Snaps, Science - March 8, 2024 Category: Science Authors: David Bradley Tags: Social Media Source Type: blogs
Micro and Nanoplastics and Cardiovascular Events – Recent Study
Use of plastics in daily life is currently on the increase and it is a well known pollutant in our water bodies like rivers, ponds, lakes and ocean. Plastics can be degraded into microplastics which are smaller than 5 mm and nanoplastics which are smaller than 1000 nanometer [1]. Microplastics and nanoparticles can trigger toxicologic effects in the body [2]. Both microplastics and nanoplastics can enter our body through ingestion, inhalation and even by topical exposure on the skin. According to a webpage from United States National Oceanic and Atmospheric Administration (NOAA), microbeads which are a type of microplastic...
Source: Cardiophile MD - March 8, 2024 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
